You're signed outSign in or to get full access.
About
Qin Yao is an international equity research analyst at Ariel Investments, based in New York, NY. In this role since 2016, she is responsible for conducting fundamental research and analysis on international equities, with a focus on identifying compelling investment opportunities in global markets for Ariel’s international portfolios.
Her sector expertise centers on life sciences, pharmaceuticals, and related industries, leveraging her prior background in molecular biology and biochemistry. Before joining Ariel Investments, Qin was a consultant at Lfi Solutions, Inc., and served as an Associate Researcher at the Icahn School of Medicine at Mount Sinai, where she contributed to advanced scientific research.
Qin holds a Doctor of Philosophy degree in Molecular Biology and Biochemistry from Huazhong University of Science and Technology as well as additional credentials from Stony Brook University. Her interdisciplinary proficiency bridges scientific innovation and investment analysis, enabling her to provide in-depth insights within the healthcare and broader international equity sectors. (Direct confirmation of her current role at Ariel Investments and full LinkedIn details were not available in public sources, but her career timeline and expertise strongly align with the provided information.)
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Ariel Investments | International Equity Research | Mar 2016 to Present | * Ariel Investments is headquartered in Chicago, with offices in New York City and Sydney. We serve individual and institutional investors through our no-load mutual funds and separate accounts. Since... |
| Lfi Solutions, Inc. | Consultant | Dec 2015 to Mar 2016 | ● Identified and evaluated 10 early-stage pharmaceutical/biotech companies; Participated in making investment decision through primary and secondary research ● Initiated an exclusive licensing deal be... |
| Icahn School of Medicine at Mount Sinai | Associate Researcher Ii | Jan 2013 to Mar 2016 | Oversaw ~$300k of institute-shared instruments on daily basis, and negotiated replacement of ~$100K worth of equipments without experiment failure or delay; Implemented lab safety protocol and SOPs wi... |
| Celdara Medical | Analyst | Sep 2015 to Jan 2016 | * Performed due diligence on a weekly basis to identify novel therapeutic candidates for further development
* Developed solutions-based strategies and introduced competitive positioning pathways |
| Esac Inc | Subject-Specific Consultant | Aug 2012 to Sep 2012 | * Drafted and presented a proposal on cloud-based data management platform with 900 terabytes of storage capacity by using Amazon web services infrastructure at MD Anderson Medical Center
* Collaborat... |
| Brookhaven National Laboratory | Postdoctoral Research Associate | Apr 2010 to Apr 2012 | * Initiated and led collaboration involving University of Chicago, BNL, Cold Spring Harbor Laboratory (CSHL), and Nobel Laureate Richard Roberts to discover 5-hydroxymethylcytosine, an important genet... |
| University of Georgia | Postdoctoral Research Associate | Sep 2007 to Feb 2010 | * Developed and optimized a novel targeted RNA sequencing protocol and 2 cloud-based data analysis pipelines; Organized 2 collaborative research projects between University of Georgia (UGA) and other ... |
| Huazhong University of Science and Technology | Associate Researcher and Group Leader | Sep 2001 to Aug 2007 | * Led and managed a team of 5 graduate students
* Initiated and designed research projects for 2 graduate students
* Oversaw ~$100k of instruments without experiments failure and delayed
* planned bud... |
| Hubei Import & Export Commodity Inspection Bureau State Government Agency | Intern | Jun 2006 to Sep 2006 | Provided expertise knowledge for inspection of imported GMO-labeled food and related product |
| Hubei Commodity Inspection Bureau | Intern | Jun 2006 to Sep 2006 | Provided expertise knowledge for inspection of imported GMO-labeled food and related product |
| Ariel Investments | Global and International Equity Research | Unknown to Present | — |
Education
Stony Brook University
2013 — 2013
Huazhong University of Science and Technology
Doctor Of Philosophy, Molecular Biology, Biochemistry
2001 — 2006
Skills & Expertise
Others at Ariel Investments, LLC (20)
| Name | Role | Location |
|---|---|---|
C Clark Chang | Research Analyst | New York, NY , United States |
 | Client Portfolio Manager | Chicago, IL , United States |
D David Kwon | Global Equity Research | New York, NY , United States |
 | Research Associate | New York, NY , United States |
J John Rogers | Founder, Chairman, Co-Chief Executive Officer and Chief Investment Officer | Chicago, IL , United States |
K Kevin Buttigieg | Equity Research Analyst | New York, NY , United States |
 | Senior Sustainable Investment Research Analyst | Chicago, IL , United States |
V Vladimir Byalik | Portfolio Manager - Emerging Markets Value | New York, NY , United States |
A Annie C | Equity Research - Healthcare | New York, NY , United States |
B Barry C. | Vice President Equity | New York, NY , United States |
